Dr Amy Cain’s research group develops various genomics-based methods to search for new antibiotic targets in nasty hospital pathogens, understand resistance to antibiotic combinations and map molecular responses to environmental stresses in difficult-to-treat bacteria. She also runs the Galleria Facility, an ethical and efficient animal model alternative, useful for testing the toxicity and efficiency of new antibiotics, and assaying the pathogenicity of bacterial strains. More Info